Skip to main content
. Author manuscript; available in PMC: 2017 Mar 4.
Published in final edited form as: RSC Adv. 2016 Mar 4;6(34):28820–28829. doi: 10.1039/C6RA00414H

Figure 4.

Figure 4

Characterization of the di-hydroxy PTAD-derivatives of docosahexaenoic acid-and n-3 docosapentaenoic acid-derived mediators protectin D1 (PD1, 2) and PD1n-3DPA (13). Products were analyzed using LC-MS/MS metabololipidomics. MRM chromatograms obtained from using (a) m/z 534->181 and (b) m/z 536 ->183. Results are representative of 3 independent preparations.